Pharma

Supreme Court Ruling Reshapes Future of Mass Tort Bankruptcy Settlements: Purdue Pharma Case Unravels Traditional Protections for Insurers

by

Washington, D.C. — In a landmark decision, the U.S. Supreme Court has issued a ruling that will reshape the landscape of bankruptcy law, particularly affecting how companies deal with mass tort liabilities through Chapter 11 bankruptcy cases. This decision notably impacts liability insurers who often resort to bankruptcy proceedings to resolve large-scale legal claims. At the center of this pivotal case is Purdue Pharma, the pharmaceutical giant behind OxyContin. This drug, marketed as a time-released painkiller, became wildly popular, turning into the most prescribed opioid in the United States. This, however, came at a steep … Read more

Law Scholar Anthony Casey’s Insights Crucial in Major Supreme Court Decision on Purdue Pharma Settlement

by

Chicago — In a landmark case, the U.S. Supreme Court recently ruled on a highly contentious bankruptcy settlement involving Purdue Pharma L.P., the maker of OxyContin, and its $6 billion proposal intended to resolve lawsuits spurred by the opioid crisis. At the heart of this legal battle was a key paragraph in the Bankruptcy Code, pivotal in determining how the courts could use bankruptcy to address mass-tort claims both swiftly and equitably. Purdue Pharma, under the ownership of the Sackler family, touched off a legal and moral storm with a proposal that included a condition … Read more

Expert in Pharma Patents, Judge Martinotti Takes on Key ANDA Litigation Cases in New Jersey

by

TRENTON, N.J. — Judge Martinotti, a presiding figure in the U.S. District Court for New Jersey, brings a rich background of experience to the bench, particularly in intricate legal battles related to pharmaceutical patents and ANDA litigation. His tenure has distinguished him as a notable jurist in the field of intellectual property rights, where stakes are particularly high due to the profound impact these decisions can have on healthcare costs and access to medicine. Martinotti’s rulings have often provided clarity in the murky waters of generic and branded pharmaceutical interactions, which are governed by the … Read more

Supreme Court to Deliver Landmark Ruling in Purdue Pharma Bankruptcy, A Potent Closure to an Opioid Saga

by

Washington, D.C. — The United States Supreme Court is poised to deliver its decision on the bankruptcy case of Purdue Pharma LP, marking a significant milestone in the ongoing battle against the opioid epidemic, a crisis responsible for over 750,000 deaths between 1999 and 2022. This forthcoming opinion is expected to address numerous legal and ethical issues surrounding one of the most notorious pharmaceutical giants in recent history. Purdue Pharma, widely criticized for its role in the opioid crisis, sought bankruptcy protection to manage the wave of lawsuits alleging it aggressively marketed OxyContin despite knowing … Read more